期刊文献+

多次小剂量STZ诱导的成年鼠糖尿病指标的自发恢复 被引量:8

Diabetes induced by multiple low doses of STZ can be spontaneously recovered in adult mice
暂未订购
导出
摘要 多次小剂量链脲佐菌素(streptozotocin,STZ)诱导的迟发型1型糖尿病成年小鼠(MLD-STZ成年鼠)血糖水平可自发恢复正常。该文试图对该现象及发生该现象的MLD-STZ成年鼠糖尿病指标进行综合分析。造模后,以放射免疫分析法、免疫荧光和HE染色等技术研究MLD-STZ鼠糖尿病各指标的变化。结果发现,糖尿病发生后,MLD-STZ鼠的摄食、饮水、体重、血糖和血清胰岛素水平等均随患病时间延长而逐渐加重,在糖尿病第20周时最为严重,此后,上述指标、胰岛β细胞量及胰岛炎症等逐渐改善。在糖尿病第36周时,尽管血糖水平正常的MLD-STZ鼠体重尚不及正常对照,但其摄食、饮水、血糖和血清胰岛素水平等尽皆恢复正常,且其胰岛内未见淋巴细胞浸润。上述结果说明MLD-STZ成年鼠糖尿病各指标可自发恢复至正常水平。 In a previous study, we observed that multiple low doses of streptozotocin (STZ) can induce spontaneous restoration of normoglycemia in adult mouse diabetes models. In the present study, we sought to identify when spontaneous recovery from diabetes occurs and to disclose the changes in the diabetic data of diabetic mice induced by multiple low doses of streptozotocin (MLD-STZ mice). After inducing type 1 diabetes mellitus, radioimmunoassay, indirect immunofluorescence and hematoxylin-eosin staining were used to determine the diabetic data of MLD-STZ mice. In MLD-STZ mice, the diabetic indicators, including food intake, water consumption, body weight, blood glucose level and serum insulin concentration, developed gradually until week 20. Thereafter, the symptoms of diabetes gradually improved. By the week 36, although body weight and β cell masses remained significantly different between the MLD-STZ mice and the age-matched control animals, food intake, water consumption, blood glucose levels and serum insulin concentrations had all returned to normal levels, and no lymphocytic infiltrations were observed in pancreatic islets. This data demonstrates that MLD-STZ can induce spontaneous recovery from diabetes mellitus in adult mice, suggesting further research into the processes by which normoglycemia is recovered.
出处 《Zoological Research》 CAS CSCD 北大核心 2013年第3期238-243,共6页 动物学研究(英文)
基金 山东省自然科学基金(2009ZRB019FB) 山东省高等学校科技计划项目(J12LK05)
关键词 链脲佐菌素 1型糖尿病 血糖 β细胞量 小鼠 Streptozotocin Type 1 diabetes mellitus Blood glucose β cell mass Mouse
  • 相关文献

参考文献16

  • 1Bahr J, Kl?ting N, Kl?ting I, Follak N. 2011. Transplantation of adipose tissue protects BB/OK rats from type 1 diabetes development. Transplant Immunology, 24(4): 238-240.
  • 2Bouwens L, Rooman I. 2005. Regulation of pancreatic beta-cell mass. Physiological Reviews, 85(4): 1255-1270.
  • 3Dunn JS, Duffy E, Gilmour MK, Kirkpatrick J, McLetchie NG. 1944. Further observations on the effects of alloxan on the pancreatic islets. The Journal of Physiology, 103(2): 233-243.
  • 4Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. 2000. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia, 43(12): 1528-1533.
  • 5Hartmann K, Besch W, Zühlke H. 1989. Spontaneous recovery of streptozotocin diabetes in mice. Experimental and Clinical Endocrinology & Diabetes, 93(2-3): 225-230.
  • 6Karabatas LM, Pastorale C, de Bruno LF, Maschi F, Pivetta OH, Lombardo YB, Chemes H, Basabe JC. 2005. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice. Pancreas, 30(4): 318-324.
  • 7Leiter EH, Prochazka M, Coleman DL. 1987. The non-obese diabetic (NOD) mouse. American Journal of Pathology, 128(2): 380-383.
  • 8Li L, Seno M, Yamada H, Kojima I. 2003. Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor cells to β-cells in streptozotocin-treated mice. American Journal of Physiology Endocrinology and Metabolism, 285(3): E577-583.
  • 9Like AA, Rossini AA. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science, 193(4251): 415-417.
  • 10Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. 2005. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?. Diabetologia, 28(11): 2221-2228.

二级参考文献33

  • 1Yang W, Lu J, Weng J, et al. Prevalence of Diabetes among Men and Women in China[ J]. The New England Journal of Medicine, 2010, 362(12) : 1090-1101.
  • 2Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic [ J]. Nature, 2001, 414(6865) : 782.
  • 3Bach J. Immunotherapy of type 1 diabetes:lessons for other antoimmune diseases[ J]. Arthritis Res, 2002, 4 ( Suppl 3) : 1-15.
  • 4Mathews C. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes [ J ]. Pediatr Diabetes, 2005, 6(3): 165-177.
  • 5Mendez J, Ramos H. Animal models in diabetes research [J]. Archives of medical research, 1994, 25(4): 367-375.
  • 6Junod A, Lambert AE, Orci L, et al. Studies of the diabetogenic action of streptozotocin. [ J]. Proc Soc Exp Biol Med, 1967, 126(1):201-205.
  • 7Wang X, Li YL, Wu H, et al. Anti-diabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent[ J]. Phytotherapy Research, 201.1, doi: 10. 1002/ptr. 3385.
  • 8Van Bellea TL, Taylora P, Von Herrath MG. Mouse models for Type 1 Diabetes [ J]. Drug Discovery Today: Disease Models, 2009, 6(2) : 41-45.
  • 9Ktorza A, Bernard C, Parent V, et al. Are animal models of diabetes relevant to the study of the genetics of non- insulin-dependent diabetes in humans [ J ]. Diabetes Metab, 1997, 23 (Suppl 2) ; 2338-2346.
  • 10Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview [ J ]. Indian Journal of Medical Research, 2007, 125 ( 3 ) : 451-472.

共引文献10

同被引文献81

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部